Ge Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ge Hu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Dong Qu
Department of Critical Care Medicine, Capital Center for Children’s Health, Capital Medical University, Capital Institute of Pediatrics, Beijing, China
1 shared publication - Haiyan Ge
Department of Critical Care Medicine, Capital Center for Children’s Health, Capital Medical University, Capital Institute of Pediatrics, Beijing, China
1 shared publication - Jinhua Wang
Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China
1 shared publication - Lan Song
Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
1 shared publication - Wei Han
Department of Epidemiology and Health Statistics, Institute of Basic Medicine Sciences, School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China
1 shared publication - Zhenchen Zhu
Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 24 September 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (10) , 2333
Assessing the Heterogeneous Treatment Effects of Glucocorticoids in Infants and Toddlers with Severe Pneumonia
Background: Community-acquired pneumonia (CAP) is a leading cause of pediatric hospitalizations and a risk factor for chronic respiratory conditions. Glucocorticoids (GCs) are used as adjunctive therapy to reduce inflammation, but their efficacy in infants and toddlers remains unclear. Method: A retrospective study of 1116 infants and toddlers with severe CAP was conducted, using causal forest to estimate individual treatment effects (ITEs), with the duration of intensive care unit (ICU) stay as the outcome. Patients were stratified based on ITEs to investigate the heterogeneous treatment effect (HTE) and identify responders. Generalized linear models validated the HTE across subclasses, followed by comparative analyses to characterize responders. Variable importance was assessed using the causal model, and Shapley additive explanations (SHAP) quantified each variable’s contribution to the ITE. Analysis was also performed in mechanically ventilated patients (MV group). Results: GCs demonstrated significant HTE. Older patients and those with elevated inflammation markers showed better responses, whereas no such benefit was observed in respiratory syncytial virus-infected patients. These subgroups experienced shorter ICU stays both in the whole cohort (β = −0.16, p < 0.001) and MV group (β = −0.34, p < 0.001), and shorter ventilation duration was observed in the MV group (β = −0.35, p < 0.001). Age and the anion gap were key predictors of ITEs. SHAP analysis revealed a positive correlation between age and GC effectiveness. Conclusions: Significant heterogeneity in GC treatment effects exists among infants and toddlers with severe CAP, highlighting the need for optimization of GC use in this population.
- 24 September 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (10) , 2333
Open AccessAssessing the Heterogeneous Treatment Effects of Glucocorticoids in Infants and Toddlers with Severe Pneumonia
Background: Community-acquired pneumonia (CAP) is a leading cause of pediatric hospitalizations and a risk factor for chronic respiratory conditions. Glucocorticoids (GCs) are used as adjunctive therapy to reduce inflammation, but their efficacy in infants and toddlers remains unclear. Method: A retrospective study of 1116 infants and toddlers with severe CAP was conducted, using causal forest to estimate individual treatment effects (ITEs), with the duration of intensive care unit (ICU) stay as the outcome. Patients were stratified based on ITEs to investigate the heterogeneous treatment effect (HTE) and identify responders. Generalized linear models validated the HTE across subclasses, followed by comparative analyses to characterize responders. Variable importance was assessed using the causal model, and Shapley additive explanations (SHAP) quantified each variable’s contribution to the ITE. Analysis was also performed in mechanically ventilated patients (MV group). Results: GCs demonstrated significant HTE. Older patients and those with elevated inflammation markers showed better responses, whereas no such benefit was observed in respiratory syncytial virus-infected patients. These subgroups experienced shorter ICU stays both in the whole cohort (β = −0.16, p < 0.001) and MV group (β = −0.34, p < 0.001), and shorter ventilation duration was observed in the MV group (β = −0.35, p < 0.001). Age and the anion gap were key predictors of ITEs. SHAP analysis revealed a positive correlation between age and GC effectiveness. Conclusions: Significant heterogeneity in GC treatment effects exists among infants and toddlers with severe CAP, highlighting the need for optimization of GC use in this population.